Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

Publisher: Karger

E-ISSN: 1664-5553|3|3-4|439-450

ISSN: 2235-1795

Source: Liver Cancer, Vol.3, Iss.3-4, 2014-08, pp. : 439-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content